Phattarataratip E, Sappayatosok K. Expression of claudin-5, claudin-7 and occludin in oral squamous cell carcinoma and their clinico-pathological significance. J Clin Exp Dent. 2016;8(3):e299-306.

 

doi:10.4317/jced.52801

http://dx.doi.org/doi:10.4317/jced.52801

 

References

1. Tsukita S, Furuse M. Overcoming barriers in the study of tight junction functions: from occludin to claudin. Genes Cells. 1998;3:569-73.
http://dx.doi.org/10.1046/j.1365-2443.1998.00212.x
PMid:9813107

 

2. Ding L, Lu Z, Lu Q, Chen YH. The claudin family of proteins in human malignancy: a clinical perspective. Cancer Manag Res. 2013;5:367-75.
PMid:24232410 PMCid:PMC3825674

 

3. Dos Reis PP, Bharadwaj RR, Machado J, Macmillan C, Pintilie M, Sukhai MA, et al. Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma. Cancer. 2008;113:3169-80.
http://dx.doi.org/10.1002/cncr.23934
PMid:18991282

 

4. Hou J. Lecture: New light on the role of claudins in the kidney. Organogenesis. 2012;8:1-9.
http://dx.doi.org/10.4161/org.19808
PMid:22504740 PMCid:PMC3399704

 

5. Frank JA. Claudins and alveolar epithelial barrier function in the lung. Ann N Y Acad Sci. 2012;1257:175-83.
http://dx.doi.org/10.1111/j.1749-6632.2012.06533.x
PMid:22671604 PMCid:PMC4864024

 

6. Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, Schmidt C, et al. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest. 2005;115:1765-76.
http://dx.doi.org/10.1172/JCI24543
PMid:15965503 PMCid:PMC1150288

 

7. Sappayatosok K, Phattarataratip E. Overexpression of Claudin-1 is Associated with Advanced Clinical Stage and Invasive Pathologic Characteristics of Oral Squamous Cell Carcinoma. Head Neck Pathol. 2015;9:173-80.
http://dx.doi.org/10.1007/s12105-014-0559-z
PMid:25078758 PMCid:PMC4424206

 

8. Ricardo S, Gerhard R, Cameselle-Teijeiro JF, Schmitt F, Paredes J. Claudin expression in breast cancer: high or low, what to expect? Histol Histopathol. 2012;27:1283-95.
PMid:22936447

 

9. Seo HW, Rengaraj D, Choi JW, Ahn SE, Song YS, Song G, et al. Claudin 10 is a glandular epithelial marker in the chicken model as human epithelial ovarian cancer. Int J Gynecol Cancer. 2010;20:1465-73.
PMid:21370593

 

10. Jung H, Jun KH, Jung JH, Chin HM, Park WB. The expression of claudin-1, claudin-2, claudin-3, and claudin-4 in gastric cancer tissue. J Surg Res. 2011;167:e185-91.
http://dx.doi.org/10.1016/j.jss.2010.02.010
PMid:20462599

 

11. Lourenco SV, Coutinho-Camillo CM, Buim ME, de Carvalho AC, Lessa RC, Pereira CM, et al. Claudin-7 down-regulation is an important feature in oral squamous cell carcinoma. Histopathology. 2010;57:689-98.
http://dx.doi.org/10.1111/j.1365-2559.2010.03685.x
PMid:21083599

 

12. Chiba T, Kawachi H, Kawano T, Kumagai J, Kitagaki K, Sekine M, et al. Independent histological risk factors for lymph node metastasis of superficial esophageal squamous cell carcinoma; implication of claudin-5 immunohistochemistry for expanding the indications of endoscopic resection. Dis Esophagus. 2010;23:398-407.
PMid:19903192

 

13. Bello IO, Vilen ST, Niinimaa A, Kantola S, Soini Y, Salo T. Expression of claudins 1, 4, 5, and 7 and occludin, and relationship with prognosis in squamous cell carcinoma of the tongue. Hum Pathol. 2008;39:1212-20.
http://dx.doi.org/10.1016/j.humpath.2007.12.015
PMid:18547615

 

14. Tobioka H, Isomura H, Kokai Y, Tokunaga Y, Yamaguchi J, Sawada N. Occludin expression decreases with the progression of human endometrial carcinoma. Hum Pathol. 2004;35:159-64.
http://dx.doi.org/10.1016/j.humpath.2003.09.013
PMid:14991532

 

15. Tobioka H, Tokunaga Y, Isomura H, Kokai Y, Yamaguchi J, Sawada N. Expression of occludin, a tight-junction-associated protein, in human lung carcinomas. Virchows Arch. 2004;445:472-6.
http://dx.doi.org/10.1007/s00428-004-1054-9
PMid:15232740

 

16. Huang GW, Ding X, Chen SL, Zeng L. Expression of claudin 10 protein in hepatocellular carcinoma: impact on survival. J Cancer Res Clin Oncol. 2011;137:1213-8.
http://dx.doi.org/10.1007/s00432-011-0987-z
PMid:21647678

 

17. Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, et al. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene. 2003;22:2021-33.
http://dx.doi.org/10.1038/sj.onc.1206199
PMid:12673207

 

18. Sobel G, Paska C, Szabo I, Kiss A, Kadar A, Schaff Z. Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma. Hum Pathol. 2005;36:162-9.
http://dx.doi.org/10.1016/j.humpath.2004.12.001
PMid:15754293

 

19. Usami Y, Chiba H, Nakayama F, Ueda J, Matsuda Y, Sawada N, et al. Reduced expression of claudin-7 correlates with invasion and metastasis in squamous cell carcinoma of the esophagus. Hum Pathol. 2006;37:569-77.
http://dx.doi.org/10.1016/j.humpath.2005.12.018
PMid:16647955

 

20. Jun KH, Kim JH, Jung JH, Choi HJ, Chin HM. Expression of claudin-7 and loss of claudin-18 correlate with poor prognosis in gastric cancer. Int J Surg. 2014;12:156-62.
http://dx.doi.org/10.1016/j.ijsu.2013.11.022
PMid:24333468

 

21. Lee JW, Lee SJ, Seo J, Song SY, Ahn G, Park CS, et al. Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia. Gynecol Oncol. 2005;97:53-9.
http://dx.doi.org/10.1016/j.ygyno.2004.11.058
PMid:15790437

 

22. Melchers LJ, Bruine de Bruin L, Schnell U, Slagter-Menkema L, Mastik MF, de Bock GH, et al. Lack of claudin-7 is a strong predictor of regional recurrence in oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 2013;49:998-1005.
http://dx.doi.org/10.1016/j.oraloncology.2013.07.008
PMid:23953778

 

23. Yoshizawa K, Nozaki S, Kato A, Hirai M, Yanase M, Yoshimoto T, et al. Loss of claudin-7 is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma. Oncol Rep. 2013;29:445-50.
PMid:23229436

 

24. Bouchagier KA, Assimakopoulos SF, Karavias DD, Maroulis I, Tzelepi V, Kalofonos H, et al. Expression of claudins-1, -4, -5, -7 and occludin in hepatocellular carcinoma and their relation with classic clinicopathological features and patients' survival. In Vivo. 2014;28:315-26.
PMid:24815833

 

25. Nakanishi K, Ogata S, Hiroi S, Tominaga S, Aida S, Kawai T. Expression of occludin and claudins 1, 3, 4, and 7 in urothelial carcinoma of the upper urinary tract. Am J Clin Pathol. 2008;130:43-9.
http://dx.doi.org/10.1309/U77A6BTEXVCA5D0E
PMid:18550469

 

26. Sakaguchi T, Suzuki S, Higashi H, Inaba K, Nakamura S, Baba S, et al. Expression of tight junction protein claudin-5 in tumor vessels and sinusoidal endothelium in patients with hepatocellular carcinoma. J Surg Res. 2008;147:123-31.
http://dx.doi.org/10.1016/j.jss.2007.07.013
PMid:17981296

 

27. Turunen M, Talvensaari-Mattila A, Soini Y, Santala M. Claudin-5 overexpression correlates with aggressive behavior in serous ovarian adenocarcinoma. Anticancer Res. 2009;29:5185-9.
PMid:20044634

 

28. Tsukita S, Yamazaki Y, Katsuno T, Tamura A, Tsukita S. Tight junction-based epithelial microenvironment and cell proliferation. Oncogene. 2008;27:6930-8.
http://dx.doi.org/10.1038/onc.2008.344
PMid:19029935

 

29. Ding L, Lu Z, Foreman O, Tatum R, Lu Q, Renegar R, et al. Inflammation and disruption of the mucosal architecture in claudin-7-deficient mice. Gastroenterology. 2012;142:305-15.
http://dx.doi.org/10.1053/j.gastro.2011.10.025
PMid:22044670 PMCid:PMC3267838

 

30. Lioni M, Brafford P, Andl C, Rustgi A, El-Deiry W, Herlyn M, et al. Dysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells. Am J Pathol. 2007;170:709-21.
http://dx.doi.org/10.2353/ajpath.2007.060343
PMid:17255337 PMCid:PMC1851859